Regenerative medicine market to triple to $38.7bn by 2024
The regenerative medicine market is predicted to develop at a CAGR of 23.8%, driven by the growing cell-based immunotherapy sector.
The regenerative medicine market is predicted to develop at a CAGR of 23.8%, driven by the growing cell-based immunotherapy sector.
Marken introduces a container for shipments of clinical drug products, clinical drug substance, as well as cell and gene therapies.